Guo, J.; Yang, W.-L.; Pak, D.; Celestino, J.; Lu, K.H.; Ning, J.; Lokshin, A.E.; Cheng, Z.; Lu, Z.; Bast, R.C., Jr.
Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer. Cancers 2019, 11, 596.
https://doi.org/10.3390/cancers11050596
AMA Style
Guo J, Yang W-L, Pak D, Celestino J, Lu KH, Ning J, Lokshin AE, Cheng Z, Lu Z, Bast RC Jr.
Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer. Cancers. 2019; 11(5):596.
https://doi.org/10.3390/cancers11050596
Chicago/Turabian Style
Guo, Jing, Wei-Lei Yang, Daewoo Pak, Joseph Celestino, Karen H. Lu, Jing Ning, Anna E. Lokshin, Zhongping Cheng, Zhen Lu, and Robert C. Bast, Jr.
2019. "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 11, no. 5: 596.
https://doi.org/10.3390/cancers11050596
APA Style
Guo, J., Yang, W.-L., Pak, D., Celestino, J., Lu, K. H., Ning, J., Lokshin, A. E., Cheng, Z., Lu, Z., & Bast, R. C., Jr.
(2019). Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer. Cancers, 11(5), 596.
https://doi.org/10.3390/cancers11050596